Neuberger Berman Group LLC 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 3:59 pm Sale |
2021-12-31 | 13G | Emergent BioSolutions Inc. EBS |
Neuberger Berman Group LLC | 646,395 1.200% |
-2,564,954 (-79.87%) |
Filing |
| 2021-02-12 08:49 am Purchase |
2020-12-31 | 13G | Emergent BioSolutions Inc. EBS |
Neuberger Berman Group LLC | 3,211,349 6.060% |
3,211,349 (New Position) |
Filing |